Lactose (India) Limited (BOM:524202)

India flag India · Delayed Price · Currency is INR
94.62
-3.00 (-3.07%)
At close: Mar 10, 2026
-21.80%
Market Cap 1.23B
Revenue (ttm) 1.45B
Net Income (ttm) 48.28M
Shares Out 12.59M
EPS (ttm) 3.85
PE Ratio 25.36
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,317
Average Volume 10,473
Open 99.57
Previous Close 97.62
Day's Range 93.57 - 99.99
52-Week Range 84.27 - 136.70
Beta 0.23
RSI 46.24
Earnings Date Feb 13, 2026

About Lactose (India)

Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India and internationally. The company offers lactose monohydrate; solid dosage forms comprising dry granulated, film, and lacquer coated tablets, as well as uncoated and blister packed solid dose forms; and liquid dosage forms. It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as w... [Read more]

Industry Pharmaceutical Preparations
Founded 1991
Employees 140
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524202
Full Company Profile

Financial Performance

In fiscal year 2025, Lactose (India)'s revenue was 1.16 billion, an increase of 2.20% compared to the previous year's 1.14 billion. Earnings were 51.63 million, a decrease of -23.95%.

Financial Statements

News

There is no news available yet.